Log in to save to my catalogue

Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids

Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1938605696

Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids

About this item

Full title

Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids

Publisher

Cham: Springer International Publishing

Journal title

Drugs (New York, N.Y.), 2017-10, Vol.77 (15), p.1665-1675

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Oral ulipristal acetate (Esmya
®
; Fibristal
®
), a synthetic selective progesterone receptor modulator, is the first selective progesterone modulator to be approved for the treatment of uterine fibroids. It was initially approved for the preoperative treatment of moderate to severe uterine fibroid symptoms in women of reproductive age....

Alternative Titles

Full title

Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1938605696

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1938605696

Other Identifiers

ISSN

0012-6667

E-ISSN

1179-1950

DOI

10.1007/s40265-017-0812-3

How to access this item